Mohanlal Babulal Bafna Impex Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 26-06-2024
- Paid Up Capital ₹ 0.82 M
as on 26-06-2024
- Company Age 16 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -90.19%
(FY 2022)
- Profit -97.82%
(FY 2022)
- Ebitda -104.50%
(FY 2022)
- Net Worth -0.52%
(FY 2022)
- Total Assets -8.96%
(FY 2022)
About Mohanlal Babulal Bafna Impex
The Corporate was formerly known as Mb Bafna Impex Limited. The Company is engaged in the Home & Lifestyle Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 0.82 M, as per Ministry of Corporate Affairs (MCA) records.
Shreepal Bafna, Nejal Bafna, Anikesh Bafna, and One other member serve as directors at the Company.
- CIN/LLPIN
U52322MH2008PLC180085
- Company No.
180085
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
14 Mar 2008
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Mohanlal Babulal Bafna Impex?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shreepal Bafna  | Director | 14-Mar-2008 | Current |
| Nejal Bafna | Director | 14-Mar-2008 | Current |
| Anikesh Bafna | Director | 26-Jul-2018 | Current |
| Madhuri Iswalkar | Director | 23-Jul-2014 | Current |
Financial Performance of Mohanlal Babulal Bafna Impex.
Mohanlal Babulal Bafna Impex Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 90.19% decrease. The company also saw a substantial fall in profitability, with a 97.82% decrease in profit. The company's net worth dipped by a decrease of 0.52%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mohanlal Babulal Bafna Impex?
In 2019, Mohanlal Babulal Bafna Impex had a promoter holding of 79.27% and a public holding of 20.73%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Anisue Healthcare Private LimitedActive 4 years 1 monthNejal Bafna and Anikesh Bafna are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Mohanlal Babulal Bafna Impex?
Unlock and access historical data on people associated with Mohanlal Babulal Bafna Impex, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mohanlal Babulal Bafna Impex, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mohanlal Babulal Bafna Impex's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
